Switching from Montek LC to Allegra at Night
Yes, you can switch from Montek LC (levocetirizine + montelukast) to Allegra (fexofenadine) at night, but this represents a change from combination therapy to antihistamine monotherapy that may reduce overall symptom control, particularly for nighttime symptoms and nasal congestion.
Understanding the Medication Difference
Montek LC contains two active ingredients:
- Levocetirizine (5 mg): A second-generation H1-antihistamine
- Montelukast (10 mg): A leukotriene receptor antagonist
Allegra (Fexofenadine) contains only:
- Fexofenadine: A second-generation H1-antihistamine 1
Key Considerations for This Switch
Efficacy Comparison
Both levocetirizine and fexofenadine are effective second-generation antihistamines for allergic rhinitis and urticaria, with patients showing variable individual responses 2
Fexofenadine has the earliest onset of action (within 30 minutes), while levocetirizine shows maximum inhibition of histamine response at 3-6 hours 3
Levocetirizine demonstrates superior wheal suppression at 2,3, and 6 hours compared to fexofenadine and desloratadine in comparative studies 3
What You'll Lose by Switching
Loss of montelukast component means:
Reduced control of nighttime symptoms, as montelukast specifically targets nighttime nasal symptoms, difficulty sleeping, and nasal congestion on awakening 4
Decreased efficacy for nasal congestion, since the combination of montelukast with antihistamines provides superior control compared to antihistamine monotherapy 5, 6
Less comprehensive inflammatory control, as the combination therapy reduces eosinophil cationic protein levels more effectively than either agent alone 5
Sedation Profile
Fexofenadine causes no sedation at recommended doses, making it an excellent choice for daytime or nighttime use without cognitive impairment 2
Levocetirizine may cause mild sedation in some patients, though it is generally well-tolerated 2
If sedation from levocetirizine is your reason for switching, fexofenadine is an appropriate alternative 2
Clinical Recommendation Algorithm
If your primary symptoms are:
Daytime sneezing, itching, rhinorrhea without significant congestion: Fexofenadine alone may be adequate 1
Nighttime symptoms, nasal congestion, or difficulty sleeping: The combination therapy (Montek LC) is superior and should be continued 4, 5
Persistent allergic rhinitis with asthma: The combination provides better control of both conditions 6
Chronic urticaria: Either fexofenadine or levocetirizine monotherapy is appropriate 1
Important Caveats
All patients should be offered a choice of at least two non-sedating H1 antihistamines because individual responses vary significantly 2
Timing adjustments can optimize drug levels: Fexofenadine's rapid onset makes it suitable for as-needed use, while the combination therapy works best with continuous daily dosing 2
Avoid taking fexofenadine with fruit juices (grapefruit, orange, apple) or aluminum/magnesium antacids, as these reduce bioavailability by 36-43% 1
If symptoms are inadequately controlled on fexofenadine alone, consider increasing the dose up to 2-4 times the FDA-approved dose (common practice for refractory cases) or adding back montelukast 2
Practical Switching Strategy
For nighttime dosing specifically: